Skip to main content

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model


Edwards Life



) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.1%. By the end of trading, Edwards Life rose $1.08 (1.1%) to $100.26 on light volume. Throughout the day, 451,422 shares of Edwards Life exchanged hands as compared to its average daily volume of one million shares. The stock ranged in a price between $99.20-$100.55 after having opened the day at $99.87 as compared to the previous trading day's close of $99.18. Other companies within the Health Services industry that increased today were:




), up 6.8%,

BSD Medical Corporation



), up 5.8%,

CombiMatrix Corporation


Scroll to Continue

TheStreet Recommends


), up 5.6%, and

Health Management Associates



), up 5.1%.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases or critically ill patients worldwide. Edwards Life has a market cap of $11.6 billion and is part of the

health care

sector. The company has a P/E ratio of 46.6, below the average health services industry P/E ratio of 48.2 and above the S&P 500 P/E ratio of 17.7. Shares are up 40.3% year to date as of the close of trading on Friday. Currently there are nine analysts that rate Edwards Life a buy, no analysts rate it a sell, and seven rate it a hold.

TheStreet Ratings rates Edwards Life as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR



) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care